AmerisourceBergen's Sean McGowan takes a closer look at US biosimilar launches
The Center for Biosimilars
For stakeholders in the US biosimilars market, the past few months have been exciting times. We’ve seen multiple product approvals, and the launch of a number of highly anticipated and long-awaited biosimilar products.